NEW YORK (GenomeWeb) – Roswell Park Cancer Institute today said that the New York State Department of Health has granted approval for the institute to test cancer patients using its OmniSeq Target molecular diagnostic test.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.
Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.
Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.
Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.